Pierre Tangermann

Pierre Tangermann has extensive work experience in various roles across different companies. Pierre started their career in 2013 as a Lecturer at HTWK Leipzig. In 2012, they joined Fraunhofer Institute for Cell Therapy and Immunology IZI as a Business Development Manager. After four years, they moved to Fraunhofer IZI-BB as the Head of Marketing and Business Development in December 2016. Pierre Tangermann currently serves as the CEO of PerioTrap Pharmaceuticals GmbH, a position they assumed in December 2018.

Pierre Tangermann's education history begins with their Bachelor of Science degree in Biochemie from Leipzig University, which they obtained from 2006 to 2009. Pierre then pursued a Master of Science degree in Biochemie, also at Leipzig University, from 2009 to 2012. Moving forward, they attended HTWK Leipzig from 2012 to 2014, where they obtained a Master of Arts degree in General Management. Additionally, in 2011 to 2012, they briefly attended The University of Queensland, although no specific degree or field of study information is provided for this period.